Mark Rolfs, DO
Family Medicine · Indianapolis, INNPI 1861781544
Payments from drug & device makers
Across 41 payments — averaging $20.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$139
- Xeris Pharmaceuticals, Inc.$131
- Bioventus LLC$77
- Neurocrine Biosciences, Inc.$77
- Lilly USA, LLC$59
- Johnson & Johnson$55
- plus $289 from 12 others
What the payments were for
- Food & beverage$827100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $139 |
| Xeris Pharmaceuticals, Inc. | 7 | $131 |
| Bioventus LLC | 3 | $77 |
| Neurocrine Biosciences, Inc. | 3 | $77 |
| Lilly USA, LLC | 3 | $59 |
| Johnson & Johnson(2 entities) | 3 | $55 |
| AbbVie | 2 | $50 |
| Novo Nordisk | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Insulet Corporation | 2 | $31 |
| Corcept Therapeutics | 1 | $23 |
| Dexcom, Inc. | 1 | $21 |
| Bayer | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Ascendis Pharma Endocrinology Inc | 1 | $15 |
| Alkermes, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
| IBSA Pharma Inc. | 1 | $11 |
How this compares
$827 in reported general payments places this provider in the 55th percentile of 2,709 family medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Indianapolis
- Blair BrengleIndianapolis$10.6M
- Steven SmithIndianapolis$2.5M
- Richard TannerIndianapolis$1.6M
- Richard FeldmanIndianapolis$476K
- Joe BanksIndianapolis$294K
- Jakoda SniderIndianapolis$107K
- Robert ClutterIndianapolis$77K
- Gaylen KeltonIndianapolis$42K
- Daniela LoboIndianapolis$38K
- Haihong MaoIndianapolis$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.